COMPANY INFO
Athelas, founded in 2015 by Deepika Bodapati and Tanay Tandon, is a healthcare technology company headquartered in Mountain View, California. With approximately 210 to 440 employees, Athelas develops FDA-cleared remote patient monitoring devices, including the Athelas One, a portable blood diagnostic device that enables patients to monitor their immune system from home, helping doctors detect conditions like leukemia and infections early. The company operates primarily in the healthcare and monitoring equipment industry, and its website is https://www.athelas.com.
Athelas Inc, founded in 2014 by Tanay Tandon and Deepika Bodapati, is a healthcare technology company headquartered in Mountain View, California. With a team of 210 to 440 employees, Athelas develops FDA-cleared remote patient monitoring devices—most notably the Athelas One, a portable diagnostic tool that empowers patients to track their immune system from home. These innovations enable early detection of medical conditions like leukemia and infections. Operating within the hospitals and health care industry, Athelas Inc is recognized for advancing patient-centric healthcare through cutting-edge monitoring equipment.
Athelas Inc funding history is marked by substantial growth, innovation, and strategic investment. The company has raised a total of $336 million across five funding rounds, leveraging resources to accelerate AI-powered healthcare transformation and expand its suite of digital health solutions. Athelas Inc investors include prominent venture capital firms such as General Catalyst, Tribe Capital, Sequoia Capital, and Y Combinator. Notably, the largest funding round occurred in June 2025 with a $200 million raise, underpinning their rapid expansion into revenue cycle management and ambient AI clinical workflows. Throughout its funding journey, Athelas Inc has prioritized scalable technology advancements and market expansion, culminating in a $6 billion acquisition by Commure in October 2023.
This major funding round was aimed at accelerating the development of AI-powered healthcare solutions, including revenue cycle management, ambient AI clinical workflows, and practice management solutions. It was led by General Catalyst’s Customer Value Fund (CVF).
Series C funding supported Athelas Inc’s rapid organizational growth, focusing on advanced sensor development and strengthening software infrastructure for remote patient monitoring.
The Series B round was used to expand Athelas Inc’s market presence and enhance the quality and reach of its remote patient monitoring services.
Athelas Inc’s Series A enabled the company to scale its operations and advance its core monitoring technologies.
This round facilitated key team expansion and accelerated development of early-stage product offerings, with Sequoia Capital as a lead investor.
Initial funding focused on developing the company’s foundational technology for remote patient monitoring.
General Catalyst is a top venture capital firm and a lead investor in several Athelas Inc funding rounds, including the $200 million growth round in 2025 and previous series rounds. Their ongoing support has been critical in fueling product innovation and market expansion at Athelas Inc.
Tribe Capital joined as a lead investor during the Series C round, providing strategic funding to scale Athelas Inc’s advanced software and sensor infrastructure. Their investment helped enable Athelas Inc’s robust growth and technological advancements.
As the lead investor in the Seed Round, Sequoia Capital played a foundational role in Athelas Inc’s early development and team expansion. The firm’s backing set the stage for future growth and successive funding success.
Initialized Capital contributed as an early-stage investor, supporting Athelas Inc’s innovation in medical device technology and digital health solutions.
Liquid 2 Ventures participated in early funding rounds, helping Athelas Inc gain traction in the healthcare technology market.
Y Combinator provided support and seed funding, fostering the company’s initial growth and positioning Athelas Inc for further investment from top venture capital firms.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Athelas Inc funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.